What are the ELN guidelines optimal responses to first-line treatment of chronic myelogenous leukemia (CML)?

Updated: May 23, 2021
  • Author: Emmanuel C Besa, MD; Chief Editor: Sara J Grethlein, MD, FACP  more...
  • Print
Answer

The optimal responses to first-line treatment are as follows [23] :

  • 3 months: Philadelphia chromosome positive (Ph+)  ≤35%, and/or BCR-ABL1≤10%

  • 6 months: : PH+ 0%, and/or BCR-ABL1 < 1%

  • 12 months: BCR-ABL1≤0.1%


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!